
- Mount Sinai Doctors
Michael Murray, MD
Internal Medicine, Genetics and Genomics
About Me
Dr. Michael F. Murray was newly appointed in July of 2023 as the Genomic Medicine Division Chief within the Department of Medicine and as the Clinical Director for the Institute for Genomic Health. He is an international expert in using DNA-derived information as a screening tool in clinical care, population health, and public health.
Prior to joining Mount Sinai Health System and Icahn School of Medicine he had the opportunity to lead cutting-edge clinical integration efforts in genomic medicine at Harvard, Geisinger, and Yale. These efforts were aimed at: Bridging the interpretation of genetic variants to the implementation of clinical care. Creating health system infrastructure for genomic risk screening and genomic diagnosis. Preparing clinicians across large health systems for the management of genomic information. Designing and executing efforts aimed at fostering patient use of actionable genomic information. And creating novel clinical strategies for “sequence once and interpret many times” workflows.
He received his medical degree from Pennsylvania State University School of Medicine in Hershey Pennsylvania. Following medical school, he went on to residency training in Internal Medicine at the Cleveland Clinic. He later completed two training fellowships first in Infectious Diseases at the University of Pennsylvania and then in Clinical Genetics Training at Harvard Medical School.
He was a community practice primary care provider for a time, and he has since held positions as a visiting scientist at the MIT Cancer Center, Clinical Chief of Genetics at Brigham and Women’s Hospital, Director of Clinical Genomics at Geisinger Health System, and Director of Clinical Operations in the Center for Genomic Health at Yale New Haven Health System. He has been on the faculty of Harvard Medical School, Geisinger Commonwealth School of Medicine, and Yale School of Medicine.
He currently serves as a member of the Board of Directors for the American College of Medical Genetics and Genomics (ACMG). He is on the Editorial Board for BMC Global and Public Health. He serves as an advisor to the National African American Precision Medicine Project.
Along with Drs. Mark Babyatsky and Monica Giovanni, he was the co-editor of “Clinical Genomics: Practical Applications for Adult Patient Care” (published by McGraw Hill). He has authored over 100 peer-reviewed publications.
He is nationally known for his work in Genomic Medicine Education. He was the Founding Director of the Combined Residency in Internal Medicine and Medical Genetics, Brigham and Women’s Hospital, and was the Director of the “Genetic Basis of Adult Medicine” an Annual CME Course at Harvard Medical School.
Language
English
Position
PROFESSOR | Medicine, Medical Genomics
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Education
MD, Pennsylvania State College of Medicine
Residency, Internal Medicine
Cleveland Clinic
Fellowship, Infectious Disease
Hospital of the University of Pennsylvania
Fellowship, Medical Genetics, Clinical Genetics (M.D.)
Harvard Medical School-Fellowship Verifications
Certifications
American Board of Medical Genetics/Clinical Genetics
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Rare germline variants in cancer-relevant genes are associated with breast cancer risk in young women with high-risk family history. Mariya Rozenblit, Tao Qing, Yixuan Ye, Hongyu Zhao, Erin Hofstatter, Vinit Singh, Emily Reisenbichler, Michael Murray, Lajos Pusztai. Breast Cancer Research and Treatment
- Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization. Tanner I. Kim, Andrew DeWan, Michael Murray, He Wang, Arya Mani, Carlos Mena-Hurtado, Raul J. Guzman, Cassius Iyad Ochoa Chaar. Annals of Vascular Surgery
- Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Anurag Verma, Jennifer E. Huffman, Alex Rodriguez, Mitchell Conery, Molei Liu, Yuk Lam Ho, Youngdae Kim, David A. Heise, Lindsay Guare, Vidul Ayakulangara Panickan, Helene Garcon, Franciel Linares, Lauren Costa, Ian Goethert, Ryan Tipton, Jacqueline Honerlaw, Laura Davies, Stacey Whitbourne, Jeremy Cohen, Daniel C. Posner, Rahul Sangar, Michael Murray, Xuan Wang, Daniel R. Dochtermann, Poornima Devineni, Yunling Shi, Tarak Nath Nandi, Themistocles L. Assimes, Charles A. Brunette, Robert J. Carroll, Royce Clifford, Scott Duvall, Joel Gelernter, Adriana Hung, Sudha K. Iyengar, Jacob Joseph, Rachel Kember, Henry Kranzler, Colleen M. Kripke, Daniel Levey, Shiuh Wen Luoh, Victoria C. Merritt, Cassie Overstreet, Joseph D. Deak, Struan F.A. Grant, Renato Polimanti, Panos Roussos, Gabrielle Shakt, Yan V. Sun, Noah Tsao, Sanan Venkatesh, Georgios Voloudakis, Amy Justice, Edmon Begoli, Rachel Ramoni, Georgia Tourassi, Saiju Pyarajan, Philip Tsao, Christopher J. O'Donnell, Sumitra Muralidhar, Jennifer Moser, Juan P. Casas, Alexander G. Bick, Wei Zhou, Tianxi Cai, Benjamin F. Voight, Kelly Cho, J. Michael Gaziano, Ravi K. Madduri, Scott Damrauer, Katherine P. Liao. Science
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Murray has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.